Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price rises 2.53% as stock trades at Rs 950
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price moved higher today, with the stock at Rs 950, up 2.53% from the previous close of Rs 926.55. The company’s market capitalisation stands at Rs 51,202.16 crore, placing the move in the context of a sizeable listed healthcare name. This Anthem Biosciences Share Price Today update confirms a same-day gain, but the supplied data does not establish a company-specific catalyst. The stock’s intraday range also gives useful context: it opened at Rs 934.10, touched a high of Rs 952.35 and a low of Rs 918.00. For readers tracking Anthem Biosciences Stock News, the day’s move is notable because it combines a higher close with a valuation profile that remains well above the broader pharmaceuticals benchmark. Univest is covering the event through price action, fundamentals, sector context and peer comparison.
Anthem Biosciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 950 |
| Previous Close | Rs 926.55 |
| Today's Move | Rs 23.45 (+2.53%) |
| Open | Rs 934.1 |
| High | Rs 952.35 |
| Low | Rs 918 |
| Turnover | Rs 38.06 crore |
| Market Capitalisation | Rs 51,202.16 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Ltd. (ANTHEM) rose to Rs 950 from the previous close of Rs 926.55, a move of Rs 23.45 or 2.53%. The stock opened at Rs 934.1, reached a high of Rs 952.35, recorded a low of Rs 918.
Anthem Biosciences Share Price today reflected a gain of Rs 23.45, or 2.53%, to Rs 950. The stock moved from the previous close of Rs 926.55 to an intraday high of Rs 952.35, after opening at Rs 934.10 and seeing a low of Rs 918.00. Turnover stood at Rs 38.06 crore. This Anthem Biosciences Share Price update confirms a positive session, while the available data does not identify a company-specific reason for the rise. In plain terms, the stock finished above the prior close and near the day’s high, which makes it a clear Anthem Biosciences stock performance event for market participants following Stocks in News and Top Gainers Today screens. Univest notes the movement as verified price action rather than a claimed catalyst-led move.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 51,202.16 crore |
| P/E Ratio | 90.66x |
| P/B Ratio | 16.68x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.53 |
| Dividend Yield | 0.22% |
Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 90.66x, P/B 16.68x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.
Anthem Biosciences Ltd. has a market capitalisation of Rs 51202.16 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 90.66x, P/B at 16.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.22, book value per share of Rs 55.53, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 90.66x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 16.68x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 51,202.16 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 90.66x, which is above the benchmark median of 32.69x, a difference of +177.33%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.78%, a difference of +86.59%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.65%, a difference of +117%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 90.66x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 51,202.16 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price rose 2.53% to Rs 950 from the previous close of Rs 926.55.
- The stock’s day high was Rs 952.35, while the day low was Rs 918.00.
- Market capitalisation stands at Rs 51,202.16 crore.
- P/E is 90.66 and P/B is 16.68, which places valuation above the sector benchmark median.
- ROE is 21.98% and ROCE is 29.62%, both above the same-industry benchmark median.
About Anthem Biosciences
Anthem Biosciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not include a longer business description, but the company is listed on the Indian market and is being tracked through its Anthem Biosciences Share Price, Anthem Biosciences Stock News and Anthem Biosciences Share Price Today movement. In an industry where valuation, return ratios and scale matter, the company’s reported market capitalisation of Rs 51,202.16 crore makes it a meaningful listed name in the dataset. For readers following Anthem Biosciences Latest News, the most useful way to understand the business today is through the verified market metrics available here: price, valuation, profitability and peer comparison. Univest will continue to place those numbers in context whenever the stock shows a fresh share price rise or other major move.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Anthem Biosciences Share Price on Univest for live price updates, stock analysis, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Anthem Biosciences Share Price Live, Anthem Biosciences Fundamental Analysis and Anthem Biosciences Stock Performance in one place. For users scanning Anthem Biosciences Share News or Anthem Biosciences News Today, that makes it easier to connect today’s price rise with the company’s valuation and sector context. Univest keeps the focus on verified data, so the stock page remains a practical reference point for ongoing market updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Anthem Biosciences Share Price rising today?
Ans. Anthem Biosciences Share Price rose 2.53% to Rs 950, but the supplied data does not establish a company-specific catalyst. The session is confirmed by the closing price, day high of Rs 952.35 and turnover of Rs 38.06 crore.
What is Anthem Biosciences Share Price Today?
Ans. Anthem Biosciences Share Price Today is Rs 950. It is above the previous close of Rs 926.55 and within the day’s range of Rs 918.00 to Rs 952.35, showing a verified same-day gain.
How much did Anthem Biosciences stock gain in the session?
Ans. Anthem Biosciences gained Rs 23.45, which translates to 2.53% for the day. The move took the stock from Rs 926.55 to Rs 950, making it a clear same-day price rise.
What is Anthem Biosciences market capitalisation?
Ans. Anthem Biosciences has a market capitalisation of Rs 51,202.16 crore. That places it well above the median market cap in the same-industry benchmark and gives context to today’s Anthem Biosciences Share Price movement.
Is Anthem Biosciences expensive compared with peers?
Ans. On the supplied numbers, Anthem Biosciences trades at a P/E of 90.66 and P/B of 16.68, both above the same-industry benchmark median. Several peers, including Cipla and Zydus Lifesciences, show lower valuation multiples.
What do ROE and ROCE show for Anthem Biosciences?
Ans. Anthem Biosciences reports ROE of 21.98% and ROCE of 29.62%. Both are above the same-industry benchmark median and average, which gives useful profitability context for Anthem Biosciences Stock Analysis. ROE stands at 21.98%.
What are Anthem Biosciences EPS, book value and dividend yield?
Ans. Anthem Biosciences EPS is Rs 10.22, book value per share is Rs 55.53 and dividend yield is 0.22%. These numbers help explain earnings per share, accounting net worth and historical payout context.
How does Anthem Biosciences compare with healthcare peers?
Ans. Anthem Biosciences has a higher P/E than Sun Pharma, Zydus Lifesciences, Cipla and several other listed peers in the supplied set. Its ROE and ROCE are also competitive against the same peer list.
